Calendar NLS Pharmaceutics Ltd.

Equities

NLSP

CH0523961370

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.1367 USD +3.25% Intraday chart for NLS Pharmaceutics Ltd. +3.01% -76.83%

Chart calendar NLS Pharmaceutics Ltd.

9.gLDi3Rc1OXZT05ZhWKYeO-bpDWFB3jhDldRahb38w8Y.zdbUn18GaSZ-4fALCPVUaL-iYTkDigoR8eQrxsqbtpnm5aSIL1R6G2C05Q~ef8505fc2b2411ae9f91e65c314a5809

Upcoming events on NLS Pharmaceutics Ltd.

No events available

Past events on NLS Pharmaceutics Ltd.

2023-12-01 10:30 am Oppenheimer Sleep Disorders Summit
2023-07-06 11:00 am Business Update Call
2023-06-30 10:00 am Annual General Meeting
2023-06-20 10:30 am Maxim Group Virtual Healthcare Conference
2023-06-06 05:00 pm American Academy of Sleep Medicine and Sleep Research Society Meeting - Poster Number: 328
2023-06-06 12:00 pm American Academy of Sleep Medicine and Sleep Research Society Meeting - Poster Number: 329
2023-06-06 12:00 pm American Academy of Sleep Medicine and Sleep Research Society Meeting - Poster Number: 327
2023-06-05 12:00 pm American Academy of Sleep Medicine and Sleep Research Society Meeting - Poster Number: 57
2023-06-05 11:15 am American Academy of Sleep Medicine and Sleep Research Society Meeting
2023-05-29 American Society of Clinical Psychopharmacology Meeting
2023-03-13 01:00 pm Roth Conference
2023-03-11 BIO CEO & Investor Conference
2023-01-31 10:00 am R&D Day
2022-09-30 10:00 am Investor Meeting - Key Opinion Leader
2022-04-28 04:00 pm B Riley Securities Virtual Neurology & Ophthalmology Conference
2022-03-30 02:00 pm Maxim Group Virtual Growth Conference
2022-03-03 03:00 pm SACHS European Life Sciences Virtual CEO Forum
2022-02-13 BIO CEO & Investor Conference - One-on-One Meetings
2021-10-05 09:00 am MicroCap Rodeo- Fall Harvest Best Ideas Conference
2021-09-13 07:00 am H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-4,20


-2,30
-2,38
3.38%
-11,9
-9,63
-23.13%
-15,5
-14,1
-9.73%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-2,86
-2,40
-19.03%
-11,9
-9,79
-22.06%
-16,5
-14,8
-11.3%
Net income
Million USD
Released
Forecast
Spread
-5,45


-2,86
-2,56
-11.89%
-11,9
-9,73
-22.81%
-16,5
-14,1
-16.74%
EPS
USD
Released
Forecast
Spread
0,00


-0,41
-0,36
-13.89%
-1,00
-0,75
-33.33%
-0,84
-0,55
-53.66%
Announcement Date31/08/2014/05/2124/03/2205/05/23

Quarterly results

Fiscal PeriodDecember 2020 S1 2020 S2 2022 S1 2022 S2 2023 S1
Net sales
Million USD
Released
Forecast
Spread






0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread



-1,22
-1,30
6.19%
-8,69
-7,68
-13.07%
-6,79
-9,40
27.72%
-7,55
-9,06
16.64%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread






-8,64
-7,71
-12.07%
-7,85
-9,40
16.44%
-7,61
-9,06
15.95%
Net income
Million USD
Released
Forecast
Spread
-1,23


-1,63
-1,48
-10.18%
-8,64
-7,71
-12.07%
-7,85
-9,40
16.44%
-7,61
-9,06
15.95%
EPS
USD
Released
Forecast
Spread
-0,18


-0,23
-0,19
-21.05%
-0,54
-0,39
-38.46%
-0,30
-0,30
0%
-0,20
-0,27
25.93%
Announcement Date19/10/2014/05/2111/10/2205/05/2306/12/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NLSP Stock
  4. Calendar NLS Pharmaceutics Ltd.